Temporin A and Bombinin H2 Antimicrobial Peptides Exhibit Selective Cytotoxicity to Lung Cancer Cells

Lucy Swithenbank1, Phillipa Cox1, Llinos G Harris1

  • 1Swansea University Medical School, Institute of Life Science, Swansea University, Swansea SA2 8PP, UK.

Scientifica
|July 18, 2020
PubMed
Abstract

Insights

Antimicrobial peptides (AMPs) bombinin H4 and temporin A show promise for treating non-small cell lung carcinoma (NSCLC). These peptides selectively kill cancer cells with minimal impact on healthy cells, suggesting potential therapeutic applications.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Antimicrobial peptides (AMPs) are explored for cancer therapy due to their selective cancer cell targeting.
  • Certain Anura AMPs demonstrate selective cytotoxicity against tumor cells.

Purpose of the Study:

  • To evaluate bombinin H2, bombinin H4, temporin A, and temporin L as potential therapeutic agents for non-small cell lung carcinoma (NSCLC).

Main Methods:

  • Cytotoxicity assays (CellTox Green) were performed on NSCLC cell lines (A549, Calu-3) and a normal epithelial cell line (Beas-2B).
  • Hemolytic activity on human erythrocytes was assessed for clinical relevance.
  • MALDI-TOF was used for cell membrane profiling to understand AMPs' mode of action.

Main Results:

  • Bombinin H4 and temporin A exhibited selective cytotoxicity against NSCLC cell lines.
  • Both peptides showed low hemolytic activity, comparable to controls.
  • Differential phospholipid profiles between cancer and normal cells suggest a mechanism for selective AMP targeting.

Conclusions:

  • Bombinin H4 and temporin A show potential for NSCLC therapy.
  • Further in vitro and in vivo studies are needed to fully understand their anticancer potential.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.5K
Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
12.7K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
3.5K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.5K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.7K